Always consult your prescriber before attempting any medication combination
Unrealistically Low Pricing Prices far below market averages often signal counterfeit products, diluted formulations, or noncompliant manufacturing
In the SUSTAIN 7 trial, gastrointestinal adverse events occurred in 43-44% of semaglutide-treated patients and 33-48% of dulaglutide-treated patients (depending on dose)
At Ivm Health, we understand that the path to better health is both a personal and financial investment
Each step up in dose brings a temporary spike in fatigue, followed by adaptation
Its usually dose, titration speed, expectation mismatch, an unrecognized plateau, or care that isnt built for obesity medicine